Features the director of FDA’s Center for Drug Evaluation and Research
Information about new product approvals, emerging safety information for cancer treatments, and other current topics in cancer drug development
Emerging safety information about drugs in conjunction with the release of Drug Safety Communications
Learn how CDER is advancing regulatory science to protect public health.
Visit the FDA/CDER SBIA Chronicles, the bi-monthly newsletter of the CDER Small Business and Industry Assistance team, to find useful information to assist in all aspects of drug marketing and regulation.